Your browser is no longer supported. Please, upgrade your browser.
ALC Alcon, Inc. daily Stock Chart
Alcon, Inc.
Index- P/E- EPS (ttm)-1.31 Insider Own30.75% Shs Outstand488.20M Perf Week1.67%
Market Cap30.97B Forward P/E31.56 EPS next Y2.01 Insider Trans0.00% Shs Float488.20M Perf Month1.47%
Income- PEG- EPS next Q0.46 Inst Own48.22% Short Float0.49% Perf Quarter7.36%
Sales7.39B P/S4.19 EPS this Y- Inst Trans- Short Ratio2.32 Perf Half Y4.84%
Book/sh39.71 P/B1.60 EPS next Y5.80% ROA- Target Price64.80 Perf Year-
Cash/sh- P/C- EPS next 5Y3.42% ROE- 52W Range53.78 - 63.73 Perf YTD12.14%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-0.46% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low17.96% ATR0.72
Employees20000 Current Ratio- Sales Q/Q6.00% Oper. Margin- RSI (14)69.80 Volatility0.70% 0.93%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.59 Prev Close63.46
ShortableYes LT Debt/Eq- EarningsMar 03 AMC Payout- Avg Volume1.04M Price63.44
Recom2.40 SMA203.25% SMA507.18% SMA2007.32% Volume617,770 Change-0.03%
Jan-08-20Initiated Argus Hold
Oct-29-19Initiated Stephens Equal-Weight
Aug-21-19Reiterated BofA/Merrill Neutral $62 → $65
Jun-24-19Initiated SVB Leerink Mkt Perform $62
Jun-14-19Initiated BTIG Research Neutral
May-10-19Initiated Robert W. Baird Outperform $68
May-02-19Initiated Credit Suisse Outperform $66
Feb-17-20 08:00AM  Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch Business Wire
Jan-29-20 09:05AM  Novartis Stock Is Rising as Earnings Inch Past Forecasts
Dec-08-19 04:08PM  3 Low Price-Book Stocks for Value Investors to Consider
Dec-07-19 05:38PM  Hedge Funds Have Never Been This Bullish On Alcon Inc. (ALC) Insider Monkey
Nov-30-19 03:07PM  Hedge Funds Love Electronic Arts (EA) Way More Than These Stocks Insider Monkey
Nov-27-19 02:42PM  A Longtime Credit Investor Says There Are Opportunities in Argentina
Nov-21-19 02:14PM  Top 5 Buys of George Soros' Firm in 3rd Quarter
Nov-19-19 04:30PM  Alcon Reports Third Quarter and Nine Months 2019 Results Business Wire
Nov-18-19 05:47PM  David Rolfe Adds 2 Tech Stocks to Portfolio in 3rd Quarter
Nov-06-19 07:01PM  Alcon to Announce Third Quarter 2019 Results Business Wire
Oct-21-19 09:00AM  Alcon Contact Lens and Cataract Innovations to Headline Clinical and Educational Program at #Academy19 Business Wire
Oct-17-19 04:28PM  Invesco European Growth Fund Starts 1 Position, Boosts 5 Others in 3rd Quarter
Oct-10-19 06:58PM  Here is What Hedge Funds Think About Alcon Inc. (ALC) Insider Monkey
Oct-09-19 08:51AM  Alcon to Highlight AcrySof IQ PanOptix Trifocal IOL Launch and Groundbreaking IOL Data at American Academy of Ophthalmology Annual Meeting Business Wire
Sep-17-19 07:23AM  The Daily Biotech Pulse: Acceleron Shelves Muscular Dystrophy Drug Trial, Aclaris Aces Late-Stage Study Benzinga
Sep-16-19 11:28PM  Alcon Prices US$2.0 Billion Senior Notes Offering Business Wire
Aug-27-19 07:29AM  The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO Benzinga
01:04AM  Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens Business Wire
Aug-21-19 03:23PM  David Rolfe Adds 4 Stocks to Portfolio in 2nd Quarter
Aug-20-19 04:30PM  Alcon Reports Second Quarter and First Half 2019 Results Business Wire
Aug-19-19 01:00AM  Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline Business Wire
Aug-16-19 07:05AM  Charts of Alcon Look Good
Jul-16-19 06:05PM  Should You Pick Up Novartis (NVS) Before Q2 Earnings? Zacks
09:00AM  Alcon to Announce Second Quarter 2019 Results Business Wire
Jul-11-19 07:05AM  Alcon Kicks off SYSTANE® Campaign With Businesswoman Barbara Corcoran, Bringing Real Relief to Female Entrepreneurs Business Wire
Jun-24-19 09:15AM  New Alcon DAILIES® COLORS Contact Lenses Give Beauty Lovers Permission to Play with Their Eye Color Every Day Business Wire
Jun-19-19 01:05PM  Alcon Takes Center Stage with Contact Lens Innovations and the iLUX® System at the 2019 Optometrys Meeting Business Wire
Jun-18-19 09:00AM  Gymnast Laurie Hernandez and Alcon Help People See Their Potential with New Eye Can, Eye Will Campaign Business Wire
May-16-19 04:05PM  Alcon, Inc. (ALC) Q1 2019 Earnings Call Transcript Motley Fool
May-15-19 05:23PM  Alcon Reports First Quarter 2019 Trading Update Business Wire
05:20PM  Alcon Reports First Quarter 2019 Trading Update Business Wire
May-08-19 11:10AM  Alcon: A Secular Grower
May-01-19 09:00AM  Alcon to Showcase New Clinical Data, Innovative Technology at American Society of Cataract and Refractive Surgery 2019 Annual Meeting Business Wire
Apr-25-19 04:00PM  Alcon to Participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences Business Wire
Apr-23-19 10:11AM  Health-care earnings: Medicare for all looms large MarketWatch
09:00AM  Alcon to Host Trading Update for First Quarter 2019 Results Business Wire
Apr-15-19 06:00AM  Alcon Stock Is Back. The Eye-care Company Deserves a Long, Hard Look.
Apr-13-19 02:13PM  Barron's Picks And Pans: CVS, Disney, McDonald's, Noble Energy And More Benzinga
Apr-12-19 07:47AM  The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug Benzinga
Apr-09-19 11:42AM  Novartis News: NVS Stock Sinks Following Alcon Spin-Off InvestorPlace
12:30AM  Alcon Debuts as Independent, Publicly Traded Company Business Wire
Alcon, Inc. develops and manufactures eye care products for eye care professionals and their patients. It offers surgical products, which include technologies and devices for cataract, retinal, glaucoma, and refractive surgery; advanced technology intraocular lenses to treat cataracts and refractive errors, such as presbyopia and astigmatism; and advanced viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery. The company also provides pharmaceutical products for elevated intraocular pressure caused by glaucoma; anti-inflammatories; anti-infective to aid in the treatment of bacterial infections and bacterial conjunctivitis; ophthalmic solutions to treat inflammation and pain associated with ocular surgery; eye inflammation and infection solutions following cataract surgery; and vitreomacular adhesion, eye and nasal allergy treatment solutions, and over-the-counter dry eye relief and ocular vitamins. In addition, it offers vision care products, such as contact lenses and lens care products; daily disposable, monthly replacement, and color-enhancing contact lenses for comfortable and convenient vision correction options; contact lens care products; multi-purpose and hydrogen-peroxide based solutions to clean, rinse, and disinfect contact lenses; rewetting drops; and daily protein removers that removes protein deposits from lenses. Alcon, Inc. was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. The company was founded in 1945 and is headquartered in Geneva, Switzerland. Alcon, Inc. was previously operating as a subsidiary of Novartis AG. Alcon, Inc.(SWX:ALC) operates independently of Novartis AG as of April 9, 2019.